Singh, R., Tatake, I. J., Sibley, J., Gangaraju, R., Martin, K. A., Rosovsky, R. P., … Peseski, A. M. (2024). Variation in Anticoagulant Hemorrhage Management Guidelines for Factor-Xa Inhibitors: A Survey and Analysis of U.S. Academic Institutions. In Blood (Vol. 144, pp. 7549–7549). American Society of Hematology. https://doi.org/10.1182/blood-2024-193712

Singh, Rishabh, Ishan J. Tatake, Joseph Sibley, Radhika Gangaraju, Karlyn A. Martin, Rachel P. Rosovsky, Diana Marie Byrnes, et al. “Variation in Anticoagulant Hemorrhage Management Guidelines for Factor-Xa Inhibitors: A Survey and Analysis of U.S. Academic Institutions.” In Blood, 144:7549–7549. American Society of Hematology, 2024. https://doi.org/10.1182/blood-2024-193712.

Singh R, Tatake IJ, Sibley J, Gangaraju R, Martin KA, Rosovsky RP, et al. Variation in Anticoagulant Hemorrhage Management Guidelines for Factor-Xa Inhibitors: A Survey and Analysis of U.S. Academic Institutions. In: Blood. American Society of Hematology; 2024. p. 7549–7549.

Singh, Rishabh, et al. “Variation in Anticoagulant Hemorrhage Management Guidelines for Factor-Xa Inhibitors: A Survey and Analysis of U.S. Academic Institutions.” Blood, vol. 144, no. Supplement 1, American Society of Hematology, 2024, pp. 7549–7549. Crossref, doi:10.1182/blood-2024-193712.

Singh R, Tatake IJ, Sibley J, Gangaraju R, Martin KA, Rosovsky RP, Byrnes DM, Lim MY, Gaddh M, Cogan J, Youkhana K, Baumann Kreuziger L, Peseski AM. Variation in Anticoagulant Hemorrhage Management Guidelines for Factor-Xa Inhibitors: A Survey and Analysis of U.S. Academic Institutions. Blood. American Society of Hematology; 2024. p. 7549–7549.